# Kymera Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Jun 30, 2025

- Company: [Kymera Therapeutics, Inc.](/companies/kymr.md) (CIK 1815442)
- Form: SCHEDULE 13D/A
- Filed: 2025-06-30
- Accepted by EDGAR: Jun 30, 2025, 20:26 ET
- Period: not reported
- Accession: 0001104659-25-064298
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1815442/000110465925064298/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1815442/000110465925064298/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1815442/000110465925064298/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Jun 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-064298. Last ingested by Listed: Oct 29, 2026, 07:17 ET. No prices; not investment advice.